← All indications
Dyspnea
Difficult or labored breathing.
Subtype terms (2)
More specific conditions that are subtypes of Dyspnea in the MeSH hierarchy.
- Dyspnea, Paroxysmal
2 drugs approved
- Platypnea Orthodeoxia Syndrome
Drugs by status
Approved for this indication (1)
Phase 3 trials (9)
Phase 2 trials (16)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (24)
- Scios
- Gilead Sciences
- Novartis
- GlaxoSmithKline
- Boehringer Ingelheim
- Midwest Cardiovascular Research Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- Aarhus University
- Maastricht University
- Dartmouth University
- Queen's University, Belfast
- Sankt Lukas Hospice
- University of Groningen
- University of Medicine and Dentistry of New Jersey
- University of Milan
- University of Pavia
- Laval University
- Princess Amalia Children's Clinic
- University of California, Los Angeles
- Skanderbog Apotek
- Innovatiefonds Zorgverzekeraars
- University of Nevada, Las Vegas
- Canadian Lung Association
- Dutch Foundation for Asthma Prevention
Organization Involved with Phase 3 Indications (21)
- The Medicines Company
- Dong-A Pharmaceutical
- NeuroRx, Inc.
- National Cancer Institute (NCI)
- Baqiyatallah Medical Sciences University
- Baylor University
- Harvard University
- Duke University
- Flinders University
- Horizon Health Network
- McGill University
- Medical University of Gdansk
- Seoul National University
- University of Rochester
- Dalhousie University
- University of Texas at Houston
- Insys Therapeutics Inc
- University of Paris
- Canadian Institutes of Health Research (CIHR)
- Government of Canada
- Nova Scotia Health Research Foundation
Organization Involved with Phase 2 Indications (22)
- AstraZeneca
- Amphastar Pharmaceuticals
- Hamilton Health Sciences Corporation
- Teva
- Synvista Therapeutics, Inc
- British Columbia Cancer Agency
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Nursing Research (NINR)
- University of Manitoba
- Fraser Health
- McMaster University
- University of Toronto
- University of Alberta
- Wake Forest University
- University of Witten/Herdecke
- University of Cologne
- Uppsala University
- Medical University of South Carolina
- A.O. Ospedale Maggiore di Lodi
- Assistance Publique - Hôpitaux de Paris
- Assertio
- Xijing Hospital
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (7)